Acceleron Pharma
XLRN
#1831
Rank
โ‚ฌ9.53 B
Marketcap
155,94ย โ‚ฌ
Share price
0.00%
Change (1 day)
14,356.94%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): โ‚ฌ95.25 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is โ‚ฌ98.37 Million. In 2020 the company made a revenue of โ‚ฌ80.71 Million an increase over the revenue in the year 2019 that were of โ‚ฌ64.55 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ95.25 M18%
2020โ‚ฌ80.71 M25.05%
2019โ‚ฌ64.55 M428.85%
2018โ‚ฌ12.2 M3.78%
2017โ‚ฌ11.76 M-51.45%
2016โ‚ฌ24.22 M53.47%
2015โ‚ฌ15.78 M23.68%
2014โ‚ฌ12.76 M-74.43%
2013โ‚ฌ49.92 M275.17%
2012โ‚ฌ13.3 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ80.39 B 81,618.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ54.77 B 55,579.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ31.38 B 31,799.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ12.51 B 12,619.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ28.68 M-70.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚ฌ90.68 M-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA